/Investor DB

6 Dimensions Capital — 2019 Investments

2 investments dated 2019 · listed companies and verified rows first · show all

TScan Therapeuticstscan.comin𝕏Jul 2019SEC filingmedium confidence

A company focused on developing clinical treatments aimed at improving patient outcomes.

BiotechHealthtechMedical DevicesBoston, US

David Southwell(Executive Officer, Director)inRobert Crane(Executive Officer)

BoardLea Hachigian(Director)Steve Kraus(Director)inCampbell Murray(Director)in

Board seatHannes Smarason· per SEC Form D · $23.3M raise · filed Jul 2019

Co-investorsAstellas Venture Management LLCBessemer Venture PartnersGV (Google Ventures)Longwood FundRA CapitalPitango

HiberCellhibercell.cominFeb 2019

HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis.

BiotechMedical Devices

Julio Aguirre-Ghiso, Ph.D.(Co-Founder)

Co-investorsARCH Venture PartnersMagnetic VenturesRaptor GroupHercules Capital, Inc.Hillhouse Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.